References
Medeiros CAM, Bruin PFC, Lopes LA, Magalhaes MC, Seabra ML, Bruin VMS (2007) Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson’s disease: A randomized, double blind, placebo-controlled study. J Neurol 254(4):459–464
Fertl E, Auff E, Doppelbauer A, Waldhauser F (1993) Circadian secretion pattern of melatonin in de novo parkinsonian patients: evidence for phaseshifting properties of l-dopa. J Neural Transm Park Dis Dement Sect 5(3):227–234
Kawinska A, Dumont M, Selmaoui B, Paquet J, Carrier J (2005) Are modifications of melatonin circadian rhythm in the middle years of life related to habitual patterns of light exposure? J Biol Rhythms 20(5):451–460
Magalhaes SC, Souza CV, Dias TR, Bruin PFC, Bruin VMS (2005) Lifestyle regularity measured by the social rhythm metric in Parkinson’s disease. Chronobiol Int 22(5):917–924
Braga-Neto P, da Silva-Junior FP, Monte FS, Bruin PFC, Bruin VMS (2004) Snoring and excessive daytime sleepiness in Parkinson’s disease. J Neurol Sci 217(1):41–45
Fahn S (2006) Levodopa in the treatment of Parkinson’s disease. J Neural Transm Suppl (71):1–15
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Medeiros, C.A.M., Carvalhedo de Bruin, P.F., Lopes, L.A. et al. Melatonin in Parkinson’s disease. J Neurol 255, 759 (2008). https://doi.org/10.1007/s00415-008-0788-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-008-0788-8